골밀도 측정기 시장 규모는 예측 기간(2025-2035년) 동안 4.4%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다. 전 세계적으로 골다공증과 골감소증의 유병률 증가와 노인 인구 증가는 골밀도 측정기의 주요 수요 촉진요인으로 작용하고 있습니다. 의료비 지출 증가와 기술 발전, 인식 개선 프로그램 및 홍보가 결합되어 골밀도 측정이 더욱 친숙해지고 있습니다. 신흥 시장에서는 의료비 지출 증가로 인해 진단 인프라가 개선되고 첨단 장비의 채택이 촉진되고 있습니다. 또한, 예방의학이 일상적인 BMD 검사를 장려하고 있습니다. 스포츠 관련 부상과 생활습관병이 증가하고 있으며, 골밀도 측정은 류마티스 관절염, 만성 신장 질환, 비만과 관련된 뼈 질환과 같은 증상에 대한 임상적 활용도가 높아지고 있습니다.
국제 골다공증 재단(International Osteoporosis Foundation)의 보고서에 따르면 골다공증 환자는 전 세계적으로 증가하고 있으며, 특히 고령화 사회에서 폐경 후 여성의 위험이 높아지고 있습니다. 국제 골다공증 재단에 따르면 2024년 2월, 골다공증은 노인들에게 상당한 영향을 미쳐 50세 이상 여성 2명 중 1명, 남성 4명 중 1명이 골절로 인한 골절이 발생할 수 있다고 합니다. 유럽, 미국, 일본에서는 7,500만 명이 골다공증에 걸린 것으로 추정됩니다. 고관절 골절의 대부분은 골다공증으로 인해 뼈가 약해진 노인들에게서 발생합니다. 미국에서는 연간 약 30만 명이 고관절 골절을 경험하고 있으며, 골절 후 1년 이내 사망률은 25%에 달할 전망입니다. 또한 환자의 25%는 병원에서 요양시설로 옮겨가고, 나머지 50%는 이전 기능을 회복하지 못합니다. 고관절 골절 후 6개월이 지나면 15%만이 혼자서 걸어서 병실을 횡단할 수 있습니다. 예측에 따르면 2018년부터 2040년까지 연간 골절 건수는 190만 건에서 320만 건으로 68% 증가하고, 관련 비용은 연간 570억 달러에서 950억 달러 이상으로 증가할 것으로 예상됩니다.
노인은 골밀도 감소로 인해 골다공증과 골절의 위험이 높기 때문에 고령화 사회의 진전은 뼈 건강검진에 대한 수요를 증가시키고 있습니다. 세계보건기구(WHO)에 따르면 2024년 10월, 모든 국가는 향후 인구통계학적 전환을 위한 보건 및 사회 시스템 준비에 심각한 문제에 직면했습니다. 2050년까지 고령자의 80%가 중저소득 국가에 거주하게 될 것이며, 고령화 과정은 이전보다 더 가속화되고 있습니다. 2020년에는 60세 이상 인구가 5세 미만 아동 수를 넘어설 것이며, 2015년부터 2050년까지 세계 인구에서 60세 이상 노인이 차지하는 비중은 12%에서 22%로 증가할 것이며, 2030년에는 세계 인구 6명 중 1명이 60세 이상이 될 것이며, 60세 이상 인구는 2020년의 10억 명에서 14억 명으로 증가할 것으로 예상됩니다.
세계의 골밀도 측정기 시장에 대해 조사했으며, 시장 개요와 함께 기술별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.
Bone Densitometer Market Size, Share & Trends Analysis Report by Technology (Axial Bone Densitometry, and Peripheral Bone Densitometry), Application (Osteoporosis and Osteopenia Diagnosis, Cystic Fibrosis Diagnosis, and Chronic Kidney Diseases Diagnosis, Rheumatoid Arthritis Diagnosis, and Body Composition Measurement), and End-User (Hospitals, Orthopedic Clinics, and Diagnostic Imaging Centers) Forecast Period (2025-2035)
Industry Overview
Bone densitometer market is anticipated to grow at a CAGR of 4.4% during the forecast period (2025-2035). The increasing prevalence of osteoporosis and osteopenia globally, coupled with a growing geriatric population, is a key demand driver for bone densitometry. Increased healthcare spending combined with technological advancement, awareness programs, and promotion have made it more accessible. In emerging markets, increased healthcare expenditure has driven better diagnostics infrastructure and adoption of advanced equipment. Preventive care is additionally driving routine BMD testing. Sports-related injuries and lifestyle diseases are on the increase, with broader clinical utilization of bone densitometry for conditions such as rheumatoid arthritis, chronic kidney disease, and obesity-related bone disorders.
Market Dynamics
Rising Prevalence of Osteoporosis
The International Osteoporosis Foundation reports a global rise in osteoporosis cases, especially among the aging population, with women at a higher risk post-menopause. According to the International Osteoporosis Foundation, in February 2024, osteoporosis has a considerable influence on older adults, with one in two women and up to one in four men over age 50 likely to experience a bone fracture due to the condition. It is estimated that 75 million people in Europe, the US, and Japan are affected by osteoporosis. Most hip fractures occur in elderly patients whose bones have become weakened by osteoporosis. The US experiences approximately 300,000 hip fractures annually, with a 25% mortality rate within a year post-fracture. Additionally, 25% of patients transition from the hospital to a nursing home permanently, while the remaining 50% are unable to regain their previous level of function. Six months after a hip fracture, only 15% of individuals can walk across a room unaided. Projections estimate that between 2018 and 2040, annual fractures will increase by 68% from 1.9 million to 3.2 million, with related costs increasing annually from $57 billion to more than $95 billion.
Rising Aging Population Driving Market Growth
The increasing aging population is increasing the demand for bone health diagnostics, as older adults are at a higher risk of osteoporosis and fractures due to declining bone density. According to the World Health Organization, in October 2024, all countries encountered significant challenges in preparing their health and social systems for the demographic transition ahead. By 2050, 80% of older adults will reside in low- and middle-income countries, and the aging process is accelerating more rapidly than before. In 2020, the population aged 60 years or over surpassed the number of children under 5 years old, and between 2015 and 2050, the proportion of the global population aged 60 years or over will increase from 12% to 22%. One in six people in the world will be 60 years or older by 2030, and the population aged 60 years or over will rise from 1 billion in 2020 to 1.4 billion.
Market Segmentation
Axial Bone Densitometry Segment to Lead the Market with the Largest Share
Axial bone densitometry is a procedure used to measure the density of the central skeleton, which includes the spine, pelvis, and hip. It is utilized for the diagnosis of osteoporosis, monitoring the treatment of osteoporosis, evaluation of fracture risk, assessment of bone loss, and detection of metabolic bone disorders. It is most helpful for postmenopausal women, elderly patients, and patients with risk factors such as history of fractures or family history. The technique is recommended for high-risk populations such as postmenopausal women, elderly people, low-trauma fracture survivors, and individuals with specific risk factors.
Osteoporosis and Osteopenia Diagnosis: A Key Segment in Market Growth
Bone densitometry tests, or DEXA scans, diagnose osteoporosis and osteopenia by determining bone mineral density (BMD). These tests detect bone degeneration diseases, such as osteoarthritis, osteomalacia, and osteoporotic fractures. The results are compared with the average BMD of a healthy individual. Testing can predict future fractures, monitor the effects of treatment, and confirm the diagnosis of osteoporosis in post-fracture patients. In elderly patients, early treatment prevents severe complications.
The global bone densitometer market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America)
Government and Private Healthcare Initiatives in Asia-Pacific
In Asia-Pacific, osteoporosis is greatly underdiagnosed and undertreated. Public health programs on bone health and the prevention of osteoporosis are essential in reducing healthcare costs and improving quality of life, especially when government agencies collaborate with private healthcare providers. For instance, in October 2024, the India Bone Health Initiative, IBHI, was recently launched by Pharmed Ltd. and coincided with World Osteoporosis Day. The initiative targets the improvement of the health and well-being of the Indian population by creating an awareness of osteoporosis, educating patients, making BMD testing accessible, early detection and prevention strategies, and collaborating with healthcare professionals. The initiative capitalizes on Pharmed's history of success with bone health initiatives, including conducting free BMD screening camps and collaborating with orthopaedicians. It seeks to develop a setting in which patients are better informed about bone health, yet less able to have meaningful discussions with healthcare providers.
North America Region Dominates the Market with Major Share
North America holds a significant share owing to the aging North American population increasing the demand for bone densitometers, which are vital diagnostic tools for monitoring bone health. According to the Population Reference Bureau's (PRB) Org., in January 2024, the American population aged 65 and older is expected to grow significantly, from 58 million in 2022 to 82 million by 2050, representing a 47% increase. This age group's proportion of the total population is anticipated to rise from 17% to 23%. Additionally, the median age of the US population has increased from 30.0 in 1980 to 38.9 in 2022, with 17 states having a median age above 40, led by Maine at 44.8 and New Hampshire at 43.3. The older population is also growing more racially and ethnically diverse, with the percentage of people who identify as non-Hispanic white expected to decline from 75 percent in 2022 to 60 percent by 2050.
The major companies operating in the global bone densitometer market include General Electric Co., Hitachi, Ltd., Hologic, Inc., FUJIFILM Holdings Corp., Echolight S.p.a., JNC International Ltd., and Xingaoyi Medical Equipment Co., Ltd. among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments